This inventor holds 1 USPTO granted patent. Top assignee: Pharma Mar, S.a.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Guido Kroemer and His Patent on Cancer Combination Therapy.
Introduction
Guido Kroemer is an inventor associated with Villejuif, France. His patent work includes a proposed combination therapy for treating solid tumours.
Latest Patents
Kroemer is listed with 1 patent: “Combination of lurbinectedin and immune checkpoint inhibitors.” The patent describes therapies combining lurbinectedin with an immune checkpoint inhibitor, such as an anti-PD-1, anti-PD-L1, or anti-CTLA-4 antibody, for the treatment of solid tumours.
Career Highlights
Kroemer is associated with PharmaMar, S.A. His listed patent reflects work on combining an anticancer compound with immunotherapy approaches.
Collaborations
Oliver Kepp is identified as a coworker, indicating a professional connection in the context of this work.
Conclusion
Guido Kroemer’s listed invention focuses on combining lurbinectedin with immune checkpoint inhibitors as a potential approach to treating solid tumours.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile